🔴 Voyager Therapeutics is trading 5% down today as yields and oil concerns pressure biotech valuations

Voyager Therapeutics is trading at $2.66, down 5.00%, as continued pressure on biotechnology and growth stocks weighs on the shares.

• Elevated Treasury yields and crude-oil inflation concerns are weighing on risk-sensitive biotech valuations; the broader market is modestly higher.
• No major company-specific announcement was identified for September 25, 2026.
• Shares fell 8.60% on September 23 and 2.44% on September 24, indicating sustained selling pressure.